Brain imaging-based biomarker of depression identified

Major depressive disorder (MDD) is not only among the most common mental illnesses, affecting more than 8% of Americans, but it is also extremely variable from one person to another. Researchers have recently begun making strides toward understanding the neurophysiology underlying different subtypes of depression, which could speed development of better treatments, but much remains to be discovered.